INFUMORPH 200

Hikma Pharmaceuticals USA Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 15, 2023
Approval ID: db9ac9e3-d761-4a99-9f34-4946ebe8f255
Products: 2 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use INFUMORPH safely and effectively. See full prescribing information for INFUMORPH. INFUMORPH (morphine sulfate), Preservative-free, injectable solution, for intrathecal or epidural infusion, using a continuous microinfusion device, CII Initial U.S. Approval: 1941

Quick Stats

Total Products2

Labelers2

Label Sections21

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.